Bigul

Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March 2018

Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. S. N. Ananthasubramanian & Co., Company Secretaries for the half year ended 31st March 2018.
13-04-2018
Bigul

Compliances - Compliance Certificate For The Period Ended March,2018

Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the compliance certificate dated 12th April 2018 for the period 1st October 2017 to 31st March 2018.
13-04-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed copies of the Notice of the Annual General Meeting and E-voting information of the Company published today, in newspapers, Business Standard and Sakal.
11-04-2018
Bigul

Notice Convening Annual General Meeting To Be Held On 8Th May 2018

We enclose herewith copy of Notice convening Annual General Meeting of the Company to be held on 8th May 2018.
10-04-2018
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aberdeen Asset Management Asia Ltd
04-04-2018
Bigul

Torrent may raise Rs 15 bn via QIP as it readies to bid for Sanofi assets

Sanofi's European generic business is worth Rs 160 billion; if the deal goes through, it would be the largest outbound acquisition by an Indian drug firm
14-03-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed copies of the Notice to shareholders of the Company published today, in newspapers, Business Standard and Sakal.
27-02-2018
Bigul

WHO nod for Shantha Bio's cholera vaccine for use at higher temperatures

Shantha Biotechnics, an affiliate of Sanofi Pasteur, has received approval from the World Health Organisation (WHO) for Shanchol, its oral cholera vaccine.The approval is for use at temperat
26-02-2018
Bigul

Fixes Book Closure for Final Dividend & AGM

Sanofi India Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from May 01, 2018 to May 08, 2018 (both days inclusive) for the purpose of Payment of Final Dividend & Annual General Meeting (AGM) of the Company to be held on May 08, 2018.The Final Dividend, if approved by the shareholders shall be payable on or after May 14, 2018.
23-02-2018
Bigul

Board recommeds Final Dividend

Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 22, 2018, inter alia, has recommended a final dividend of Rs. 53 per equity share of Rs. 10 for the year ended December 31, 2017. An interim dividend of Rs.18 per equity share of Rs.10 was paid in August 2017. The interim dividend and the proposed final dividend totalling to Rs 71 per equity share of Rs 10, will together amount to a distribution...
22-02-2018
Next Page
Close

Let's Open Free Demat Account